Clinical Trial Update: Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva [Phase 3]

View source ↗

Summary

This Phase 3 trial by Boehringer Ingelheim evaluated the acute bronchodilator response of ipratropium (Atrovent) or fenoterol (Berotec) added to steady-state ti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Atrovent (ipratropium bromide)
• Berotec (fenoterol)
• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED